Novus Biologicals™ p14ARF/CDKN2A Recombinant Protein Antigen

Description

Recombinant Protein

Specifications

• For Use With (Application): Antibody Competition
• Formulation: PBS and 1 M Urea, pH 7.4.
• Gene ID (Entrez): 1029
• Molecular Weight (g/mol): MolecularWeight-theroretical: 25 kDa
• Quantity: 100 μL
• Storage Requirements: Store at -20°C. Avoid freeze/thaw cycles.
• Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2 A, cyclin-dependent kinase inhibitor 2 A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16
• Gene Symbol: CDKN2A
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Inhibitor Properties: This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP3-05521. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL
• Form: Purified
• Research Category: ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, p53 Pathway, Transcription Factors and Regulators, Tumor Suppressors
• Purity or Quality Grade: >80% by SDS-PAGE and Coomassie blue staining
• Protein: p14ARF/CDKN2A